CD8A and neoplasm: As expected, mice without CD8+ T-cells transfusions, mice treated with CD8+ T cells plus CD45RA−CCR7− Tregs or control IgG-treated CD45RA−CCR7− Tregs showed tumor growth and disease progression (Figure 5a).